Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice

Girish, Chandrashekaran; Raj, Vishnu; Arya, Jayasree; Sadasivam, Balakrishnan

doi:10.1016/j.ejphar.2012.02.034

Cited by 82 publications

(62 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This bioflavonoid has antioxidant, antifibrotic, anti-inflammatory, cardio-protective and anti-cancer properties (24). Girish et al reported anti-depressant-like effect of ellagic acid, which is associated to its interaction with serotonergic and adrenergic system (25). Girish et al assessed anxiolytic effect of ellagic acid.…”

Section: Discussionmentioning

confidence: 99%

Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests

Farbood

Mansouri

Ahmadian

et al. 2015

Jentashapir J Health Res

View full text Add to dashboard Cite

Background: Anxiety is one the most common psychiatric disorders. Recently, anti-oxidants have been shown to possess anxiolytic properties. Objectives: The present study aimed to investigate anxiolytic effect of ellagic acid (EA) in mice and its interaction with GABAA receptor. Materials and Methods: 184 male albino mice (25 -30 g) were randomly assigned into two subgroups (12 groups in each). In the first set of experiments, to evaluate acute administration of EA (single dose) on anxiety, experimental groups (10 groups, 8 mice per group) were control (received vehicle), EA-treated groups (received ellagic acid, 3, 10, 30 and 100 mg/kg, i.p.), diazepam (DZP)-treated groups (received DZP, 1, 3 and 5 mg/kg, i.p.), Flumazenil (FLZ) + diazepam-treated group (received FLZ, 3 mg/kg and + DPZ, 5 mg/kg, i.p.) and FLZ+EA-treated group (received FLZ, 3 mg/kg and ellagic acid, 30 mg/kg, i.p.). Moreover, in the first set of experiments, to evaluate the effect of chronic administration of EA on anxiety, experimental groups (2 groups, 8 mice per group) were control (received vehicle once a day for 10 days) and EA-treated group (received ellagic acid at the dose of 30 mg/kg, i.p. once a day for 10 days). In the second set of experiments, to evaluate acute (single dose) and chronic (for 10 days) administration of EA on motor activity, animal groupings were similar to the first set of experiment. Elevated plus maze (EPM) and open field tests used to study anxiolytic and motor activity effect of EA, respectively. Statistical analysis was performed by one-way ANOVA and post hoc Tukey's test. P values less than 0.05 were considered as significant. Ellagic acid at the dose of 100 mg/kg significantly decreased ambulatory movement compared with the control, while EA at the dose of 30 mg/kg did not affect ambulation. Conclusions: Acute and chronic administration of ellagic acid had anxiolytic property. Also, the most effective dose of ellagic acid was 30 mg/kg. Pretreatment with flumazenil reversed the beneficial effect of ellagic acid and diazepam on anxiety. It is likely that the anxiolytic effect of ellagic acid is largely mediated by activation of GABAA receptor.

show abstract

Section: Discussionmentioning

confidence: 99%

Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests

Farbood

Mansouri

Ahmadian

et al. 2015

Jentashapir J Health Res

View full text Add to dashboard Cite

show abstract

“…In a study ellagic acid also produces anti anxiety-like effect which was antagonized by a non-competitive GABAA receptor antagonist and a benzodiazepine site antagonist which shows modulation of GABAergic system by EA [140] . Receptorfor advanced glycation endproducts (RAGE), is a tentative cell membrane receptor for Aβ, binds to Aβ with high affinity [141] .…”

Section: Ellagic Acid and Depressionmentioning

confidence: 99%

“…In vitro antidepressant potential of ellagic acid was found in MAO-A inhibition assay [114] . Further, ellagic acid produce antiimmobility effect in anti-depressant models mediated through monoaminergic system (serotonergic and noradrenergic systems) [131] . Pretreatment with prazosin (an alpha-adrenoceptor antagonist) and p-CPA (serotonin synthesis inhibitor) reverse the anti depressive effect of ellagic acid where ellagic acid interacts with α-adrenoceptors and serotonergic receptors to produce anti depressive effect [128] .…”

Section: Ellagic Acid and Depressionmentioning

confidence: 99%

Polyphenol Ellagic Acid-Targeting To Brain: A Hidden Treasure

Mehan¹,

Kaur²,

Parveen³

et al. 2015

International Journal of Neurology Research

View full text Add to dashboard Cite

Alzheimer's disease is a severe neurodegenerative disorder that gradually results in loss of memory and impairment of cognitive functions in the elderly.Thedeposition of amyloid plaques is the primary event that leads to an oxidative and inflammatory reactions, neurofibrillary tangle formation, and ultimately neuronal death. The most prominent losses occur with cholinergic neurons that plays an important role in the formation of memory and cognitive functions. Insulin receptor numbers also altered, thusglucosemetabolism is defected in AD. Polyphenol ellagic acid (EA) possesses antioxidant, anti-inflammatory, anti-carcinogenic, anti-diabetic and cardioprotection activities.Activities of EA that are linked with protection of neuronal abnormalities like anti-depressant, antianxiety, anti-nociception. Ellagic acid inhibits β-secretase enzymatic activities, thus prevents the main pathologic hallmark of AD. There are varieties of herbal extracts and phytochemicals formulations extensively used to provide symptomatic relief to AD patients. Together these results our hypothesis that EA may prevent the neuronal dysfunctions as well as further work is also required to examine the pharmacological properties of EA in the protection of specially neurodegenerative disorder like AD. Here, we discuss how we can use the knowledge to improve treatment strategies of EA in AD and to explore the various signaling pathways involved in the progression of neuronal death.

show abstract

“…It has been demonstrated that acute oral administration of EA or extract contains EA causes modulation of monoaminergic system (serotonergic and adrenergic), and this represents the mechanism of the antidepressant activity of EA [59,60]. The intimate mechanism by which EA could manipulate the monoaminergic system has remained obscure.…”

Section: Kotob Et Almentioning

confidence: 99%

Quercetin and Ellagic Acid in Gastric Ulcer Prevention: An Integrated Scheme of the Potential Mechanisms of Action From in Vivo Study

Kotob

Sayed

Mohamed

et al. 2018

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Objective: The present study was initiated to describe the gastroprotective role of quercetin (Qu) and ellagic acid (EA) on aspirin-induced gastric ulcer (GU) in rats.Methods: Forty adult female albino rats of Wistar strain were distributed into: Control group, GU group, Omeprazole group, Qu group, and EA group. Gross examination, biochemical analyses including serum adrenocorticotropic hormone (ACTH), serotonin (ST), ferritin, heme oxygenase-1 (HO-1), interleukin-2 (IL-2), advanced glycosylation end products (AGEs), and fibronectin (FN) levels were estimated. Moreover, histopathological and histochemical examinations of stomach tissue samples were carried out.Results: Gross examination of gastric mucosa of rats in GU group revealed hyperemia of the stomach mucosa. Furthermore, rats in GU group experienced a significant rise in serum ACTH, ferritin, HO-1, IL-2 and AGEs levels accompanied with significant drop in serum ST and FN levels versus control counterparts. Pre-treatment of GU group with Omeprazole, Qu or EA caused marked improvement in the measured biochemical parameters. Histopathological and histochemical examinations of stomach tissue samples documented the protective action of Omeprazole, Qu and EA with different degrees against GU caused by aspirin. Conclusion:As a conclusion to this study, we can state that both Qu and EA have gastroprotective effect against aspirin-induced GU in rat model. Of note, Qu showed superior impact than EA as an antiulcer agent in this study. The corresponding mechanisms are speculated to be associated with inhibiting stress-induced gastric lesion, attenuating the oxidative stress, iron chelation and blunting ferritin level, modulating inflammatory cascade, and promoting the healing process.

show abstract

Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice

Cited by 82 publications

References 53 publications

Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests

Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests

Polyphenol Ellagic Acid-Targeting To Brain: A Hidden Treasure

Quercetin and Ellagic Acid in Gastric Ulcer Prevention: An Integrated Scheme of the Potential Mechanisms of Action From in Vivo Study

Contact Info

Product

Resources

About